Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
| ASP-EUG | SCBEUEQE | |
|---|---|---|
| Held by both | ||
 Roche | 4.08% | 1.94% |
 Novartis | 2.89% | 1.81% |
 Siemens | 3.18% | 1.55% |
| Only in ASP-EUG | ||
 ING | 3.28% | N/A |
 UBS Group | 3.18% | N/A |
| Rexel | 3.18% | N/A |
 Standard Chartered | 3.08% | N/A |
| Only in SCBEUEQE | ||
 ASML | N/A | 4.65% |
 HSBC | N/A | 2.26% |
 Shell | N/A | 1.74% |
 AstraZeneca | N/A | 1.67% |
30 Dec 2025 → 3 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| SCBEUEQE | +10.24% | 12.67% | 0.81 |
| ASP-EUG | +6.54% | 13.54% | 0.48 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | ASP-EUG | SCBEUEQE |
|---|---|---|
Fund details | ||
| Fund size | 121 million | 162 million |
| Inception date | 29 Jan 2021 | 26 Feb 2014 |
| Master fund | Wellington Focused European Equity Fund | AMUNDI STOXX EUROPE 600 |
| Dividend policy | Does not pay | Does not pay |
Risk and currency hedging | ||
| Risk level | 6 | 6 |
| Hedging policy | Almost fully hedged | Almost fully hedged |
| Share hedged | 100.78% | 99.46% |
Minimum purchase and redemption | ||
| First purchase | 1,000 THB | 1 THB |
| Subsequent purchase | 1,000 THB | 1 THB |
| Redemption (amount) | No minimum | 1 THB |
| Redemption (units) | No minimum | No minimum |
| Balance (amount) | No minimum | 1 THB |
| Balance (units) | No minimum | No minimum |
Order cut-off and redemption payment | ||
| Buy before | 15:00 | 15:30 |
| Redeem before | 15:00 | 15:30 |
| Redemption paid | T+4 | T+3 |
